Amatsigroup buys Q Biologicals in 'fragmented' EU bio-services space
French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.
French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.
Austrianova has launched cell banking and fill finish services for cell therapy developers at its facility in Singapore.
Four months since acquiring Pall Corporation, Danaher has reported a 34% year-on-year increase in sales from its life sciences segment.
China’s food and drug administration recently gave the nod to the Beijing-based Sinovac to manufacture a vaccine to possibly prevent hand, foot and mouth disease (HFMD), a common contagious viral infection among young children.